Company: IMRX
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001790340-25-000104
Chunk: 317

Company: Immuneering Corp
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 3
Chunk 317
---
 Extension Calculation Linkbase Document.*101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.*101.LABInline XBRL Taxonomy Extension Label Linkbase Document.*101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.*104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*

*    Filed herewith.

**    Furnished herewith.

#    Indicates management contract or compensatory plan.

94

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized. 

IMMUNEERING CORPORATIONDate: August 13, 2025By:/s/ Benjamin J. ZeskindName:Benjamin J. Zeskind, Ph.D.Title:Co-Founder, President, Chief Executive Officer and Director (Principal Executive Officer)Date: August 13, 2025By:/s/ Mallory MoralesName:Mallory MoralesTitle:Chief Accounting Officer and Treasurer(Principal Financial Officer and Principal Accounting Officer)

95